1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Blood Transfusion Diagnostics Market?
The projected CAGR is approximately 17.5%.
+1 2315155523
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
U.S. Blood Transfusion Diagnostics MarketU.S. Blood Transfusion Diagnostics Market by Product (Instruments, Reagents & Kits), by Application (Blood Screening, Blood Group Typing), by End-user (Hospital-based Laboratories, Independent Laboratories & Blood Banks), by Forecast 2026-2034
The U.S. Blood Transfusion Diagnostics Market size was valued at USD 1.91 USD billion in 2023 and is projected to reach USD 5.91 USD billion by 2032, exhibiting a CAGR of 17.5 % during the forecast period. The increasing prevalence of blood-borne diseases, rising demand for blood transfusions, and technological advancements in the field are driving the market growth. The U.S. blood transfusion diagnostics market is a critical segment of the healthcare industry, focused on ensuring the safety and compatibility of blood transfusions. This market can be grouped into broad categories, including blood typing reagents, infectious disease screening and confirmation reagents and kits, and highly sensitive diagnostic technologies like nucleic acid amplification tests. Factors that fuel growth for this market include higher incidence of chronic diseases, population aging, and higher prevalence in surgical operations that necessitate blood transfusion. Besides that, expanding application of diagnostic technologies in medicine and high requirements to the quality of tests also boosts the market development due to increased accuracy and safety. As a whole, the U. S. blood transfusion diagnostics market is a significant component in protecting as well as enhancing the quality of the blood transfusion services, which in turn influences patients’ fate and results.
Product:
Application:
End-user:
The U.S. blood transfusion diagnostics market is poised for substantial growth, particularly in the Western region. This is attributed to the concentration of major healthcare centers, research institutions, and a relatively high prevalence of blood-borne diseases in this area. However, growth is anticipated across all regions, driven by the factors outlined above and the nationwide need for safe and efficient blood transfusion practices.
DROCT analysis will be included in the market report.
Pricing analysis will be included in the market report.
Import and export analysis will be included in the market report.
Patent/Trademark analysis will be included in the market report.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 17.5% from 2020-2034 |
| Segmentation |
|
Note*: In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 17.5%.
Key companies in the market include QUOTIENT LIMITED (Switzerland), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Beckman Coulter, Inc. (Danaher) (U.S.), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (U.S.).
The market segments include Product, Application, End-user.
The market size is estimated to be USD 1.91 USD billion as of 2022.
Increasing Prevalence of Heart Diseases to Increase the Demand for Drug-eluting Balloon Catheters.
Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
Adverse Reactions Associated with Blood Transfusion Processes May Hinder Market Growth Prospects.
N/A
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.
The market size is provided in terms of value, measured in USD billion and volume, measured in 1,000 Units.
Yes, the market keyword associated with the report is "U.S. Blood Transfusion Diagnostics Market," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the U.S. Blood Transfusion Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.